Lucosky Brookman congratulates its client, Brain Scientific, (OTCQB: BRSF) (the “Company”), a medical technology company with multiple patents and FDA-cleared products, on its successful private placement of $5.6 million of senior secured convertible debentures and warrants, and converting approximately $12.9 million of existing debt into equity.
